BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36038612)

  • 1. Disease-related protein co-expression networks are associated with the prognosis of resectable node-positive pancreatic ductal adenocarcinoma.
    Nishimura T; Takadate T; Maeda S; Suzuki T; Minowa T; Fukuda T; Bando Y; Unno M
    Sci Rep; 2022 Aug; 12(1):14709. PubMed ID: 36038612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation.
    Nolan-Stevaux O; Lau J; Truitt ML; Chu GC; Hebrok M; Fernández-Zapico ME; Hanahan D
    Genes Dev; 2009 Jan; 23(1):24-36. PubMed ID: 19136624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer.
    Onishi H; Kai M; Odate S; Iwasaki H; Morifuji Y; Ogino T; Morisaki T; Nakashima Y; Katano M
    Cancer Sci; 2011 Jun; 102(6):1144-50. PubMed ID: 21338440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma.
    Maréchal R; Bachet JB; Calomme A; Demetter P; Delpero JR; Svrcek M; Cros J; Bardier-Dupas A; Puleo F; Monges G; Hammel P; Louvet C; Paye F; Bachelier P; Le Treut YP; Vaillant JC; Sauvanet A; André T; Salmon I; Devière J; Emile JF; Van Laethem JL
    Clin Cancer Res; 2015 Mar; 21(5):1215-24. PubMed ID: 25552484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway.
    Li H; Jiang W; Liu XN; Yuan LY; Li TJ; Li S; Xu SS; Zhang WH; Gao HL; Han X; Wang WQ; Wu CT; Yu XJ; Xu HX; Liu L
    Oncogene; 2020 Sep; 39(36):5825-5838. PubMed ID: 32753651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.
    Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X
    Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.
    Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H
    Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
    Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
    Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
    Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
    J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
    Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
    Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
    [No Abstract]   [Full Text] [Related]  

  • 11. High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
    Song Y; Tang MY; Chen W; Wang Z; Wang SL
    Dis Markers; 2020; 2020():7656031. PubMed ID: 33029256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
    Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
    J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Tang R; Ji J; Ding J; Huang J; Gong B; Zhang X; Li F
    Cell Cycle; 2020 Jul; 19(13):1602-1610. PubMed ID: 32420813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
    Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
    Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
    Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
    Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
    Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ
    Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome.
    Dugnani E; Sordi V; Pellegrini S; Chimienti R; Marzinotto I; Pasquale V; Liberati D; Balzano G; Doglioni C; Reni M; Gandolfi A; Falconi M; Lampasona V; Piemonti L
    Pancreatology; 2018 Dec; 18(8):945-953. PubMed ID: 30293872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
    Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between hypoxia-sensing ULK1/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development.
    Jia Y; Li HY; Wang Y; Wang J; Zhu JW; Wei YY; Lou L; Chen X; Mo SJ
    Int J Biol Sci; 2021; 17(11):2772-2794. PubMed ID: 34345207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.